| EU/EEA | non-EU/EEA |  | ||
---|---|---|---|---|---|
 | N = 25 | % | N = 19 | % | p-value |
National coordination | Â | Â | Â | Â | Â |
 Existence of a written national strategy or plan that focuses exclusively or primarily on the prevention and control of viral hepatitis and includes a surveillance component | 6 | 24.0 | 6 | 31.6 | 0.412 |
Routine surveillance of viral hepatitis B and C | Â | Â | Â | Â | Â |
 National surveillance system for acute HBV | 25 | 100 | 18 | 94.7 | 0.432 |
 National surveillance system for acute HCV | 23 | 92.0 | 18 | 94.7 | 0.604 |
 National surveillance system for chronic HBV | 18 | 72.0 | 10 | 52.6 | 0.157 |
 National surveillance system for chronic HCV | 17 | 68.0 | 10 | 52.6 | 0.234 |
 Standard case definitions for viral hepatitis infections | 25 | 100 | 17 | 89.5 | 0.181 |
 Regular hepatitis disease reports published | 22 | 88.0 | 17 | 89.5 | 0.632 |
 Hepatitis outbreaks required to be reported to the government and further investigated | 23 | 92.0 | 19 | 100 | 0.317 |
 Adequate laboratory capacity nationally to support hepatitis outbreak investigations and other surveillance activities for HBV and HBC | 25 | 100 | 19 | 100 | - |
Other sources of strategic information and capacities for disease burden estimation | Â | Â | Â | Â | Â |
 Deaths, including from hepatitis, reported to a central registry | 25 | 100 | 17 | 89.5 | 0.181 |
 Liver cancer cases registered nationally | 22 | 88.0 | 13 | 68.4 | 0.122 |
 Cases of HIV/hepatitis co-infection registered nationally | 16 | 64.0 | 13 | 68.4 | 0.508 |
 Viral hepatitis serosurveys conducted regularly | 10 | 40.0 | 10 | 52.6 | 0.299 |
  If yes, please specify the target populations: |  |  |  |  |  |
   - children | 3 | 12.0 | 2 | 10.5 | 0.632 |
   - general population | 8 | 32.0 | 3 | 15.8 | 0.191 |
   - people who inject drugs | 6 | 24.0 | 6 | 31.6 | 0.412 |
   - men who have sex with men | 3 | 12.0 | 6 | 31.6 | 0.112 |
   - other groups | 7 | 28.0 | 10 | 52.6 | 0.089 |
 All pregnant women screened for HBV | 21 | 84.0 | 13 | 68.3 | 0.195 |
 All donated blood (including family donations) screened for HBV | 25 | 100 | 17a | 94.4 | 0.419 |
 All donated blood (including family donations) screened for HCV | 25 | 100 | 18a | 100 | 0.432 |
Areas in which Member States might want assistance from WHO | Â | Â | Â | Â | Â |
 National plan | 6 | 24.0 | 11 | 57.9 | 0.024 |
 Surveillance | 2 | 8.0 | 8 | 42.1 | 0.010 |
 Burden estimation | 6 | 24.0 | 9 | 47.4 | 0.097 |